Recruiting Pulmonary Hypertension Studies in Birmingham
About Pulmonary Hypertension Clinical Trials in Birmingham
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 52 pulmonary hypertension clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 26,916 participants. Research is being sponsored by National Cancer Institute LAO, University of Alabama at Birmingham, Stratpharma AG and 34 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Birmingham — FAQ
Are there pulmonary hypertension clinical trials in Birmingham?
Yes, there are 52 pulmonary hypertension clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 52 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated September 1, 2026 from ClinicalTrials.gov